D-Index & Metrics Best Publications
Immunology
Hungary
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 62 Citations 10,544 165 World Ranking 1555 National Ranking 1
Medicine D-index 72 Citations 17,840 304 World Ranking 14171 National Ranking 4

Research.com Recognitions

Awards & Achievements

2022 - Research.com Immunology in Hungary Leader Award

2020 - Member of Academia Europaea

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Cancer

Zoltán Szekanecz focuses on Immunology, Rheumatoid arthritis, Internal medicine, Arthritis and Pathology. His biological study spans a wide range of topics, including Angiogenesis and Neovascularization. Zoltán Szekanecz has included themes like Autoantibody, Endocrinology, Disease and Systemic inflammation in his Rheumatoid arthritis study.

His research integrates issues of Gastroenterology and Cardiology in his study of Internal medicine. His studies in Arthritis integrate themes in fields like Endothelium, Physical therapy, Antigen and Risk factor. His study focuses on the intersection of Pathology and fields such as Erythrocyte sedimentation rate with connections in the field of BASFI.

His most cited work include:

  • EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (1022 citations)
  • EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (500 citations)
  • Macrophages and their products in rheumatoid arthritis. (258 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Rheumatoid arthritis, Immunology, Internal medicine, Arthritis and Gastroenterology. The concepts of his Rheumatoid arthritis study are interwoven with issues in Disease and Endothelial dysfunction. His Immunology study frequently links to adjacent areas such as Angiogenesis.

His work deals with themes such as Pathology, Endocrinology and Cardiology, which intersect with Internal medicine. His Gastroenterology study combines topics from a wide range of disciplines, such as Antibody and Rituximab. His Inflammation research integrates issues from Tumor necrosis factor alpha and Cell adhesion molecule.

He most often published in these fields:

  • Rheumatoid arthritis (43.07%)
  • Immunology (42.09%)
  • Internal medicine (40.15%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (40.15%)
  • Rheumatoid arthritis (43.07%)
  • Rheumatology (12.17%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Rheumatoid arthritis, Rheumatology, Osteoporosis and Arthritis. His study in the field of Etanercept, Bone density and Infliximab also crosses realms of Sclerostin. His Rheumatoid arthritis research is multidisciplinary, incorporating elements of Gastroenterology, Disease, Systemic inflammation and Intensive care medicine.

Zoltán Szekanecz has researched Disease in several fields, including Inflammation, Immunology, Heart disease, Drug and Comorbidity. His Immunology research is multidisciplinary, incorporating perspectives in Vascular pathology and Depression. His studies deal with areas such as Cancer research, Angiogenesis and Growth factor as well as Arthritis.

Between 2018 and 2021, his most popular works were:

  • 2018 update of the EULAR recommendations for the management of hand osteoarthritis (94 citations)
  • EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases. (20 citations)
  • EULAR definition of difficult-to-treat rheumatoid arthritis (18 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

His main research concerns Internal medicine, Rheumatoid arthritis, Rheumatology, Disease and Inflammation. His work on Etanercept, Osteoporosis and Transcranial Doppler as part of general Internal medicine study is frequently linked to Cost–utility analysis, bridging the gap between disciplines. His study in Rheumatoid arthritis focuses on Synovitis in particular.

Zoltán Szekanecz combines subjects such as Synovial Cell, Cancer research, Angiogenesis, Neovascularization and Inflammatory arthritis with his study of Inflammation. Zoltán Szekanecz usually deals with Systemic inflammation and limits it to topics linked to Cognition and Immunology. Specifically, his work in Immunology is concerned with the study of Inflammasome.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

M J Peters;D P M Symmons;D McCarey;B A Dijkmans.
Annals of the Rheumatic Diseases (2010)

1983 Citations

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

R. Agca;S. C. Heslinga;S. Rollefstad;M. Heslinga.
Annals of the Rheumatic Diseases (2017)

996 Citations

2016 update of the EULAR recommendations for the management of early arthritis

Bernard Combe;Robert Landewe;Claire I Daien;Charlotte Hua.
Annals of the Rheumatic Diseases (2016)

364 Citations

Macrophages and their products in rheumatoid arthritis.

Zoltán Szekanecz;Alisa E Koch;Alisa E Koch.
Current Opinion in Rheumatology (2007)

346 Citations

Vitamin D and autoimmune thyroid diseases

Shaye Kivity;Nancy Agmon-Levin;Michael Zisappl;Yinon Shapira.
Cellular & Molecular Immunology (2011)

345 Citations

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

H. Amital;Z. Szekanecz;G. Szücs;K. Dankó.
Annals of the Rheumatic Diseases (2010)

332 Citations

Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases.

Hedi Orbach;Gisele Zandman-Goddard;Gisele Zandman-Goddard;Howard Amital;Howard Amital;Vivian Barak.
Annals of the New York Academy of Sciences (2007)

299 Citations

Genetics of rheumatoid arthritis - A comprehensive review

Júlia Kurkó;Timea Besenyei;Judit Laki;Tibor T. Glant.
Clinical Reviews in Allergy & Immunology (2013)

298 Citations

Chemokines and chemokine receptors in rheumatoid arthritis.

Zoltán Szekanecz;Joon Kim;Alisa E Koch.
Seminars in Immunology (2003)

296 Citations

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

Ernest Choy;Kandeepan Ganeshalingam;Anne Grete Semb;Zoltán Szekanecz.
Rheumatology (2014)

272 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Zoltán Szekanecz

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 123

George D. Kitas

George D. Kitas

Dudley Group NHS Foundation Trust

Publications: 86

Alisa E. Koch

Alisa E. Koch

University of Michigan–Ann Arbor

Publications: 71

Miguel A. González-Gay

Miguel A. González-Gay

University of the Witwatersrand

Publications: 70

Howard Amital

Howard Amital

Sheba Medical Center

Publications: 49

Paul P. Tak

Paul P. Tak

GlaxoSmithKline (United Kingdom)

Publications: 43

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 37

Peter Szodoray

Peter Szodoray

Oslo University Hospital

Publications: 33

Nancy Agmon-Levin

Nancy Agmon-Levin

Sheba Medical Center

Publications: 33

Iain B. McInnes

Iain B. McInnes

University of Glasgow

Publications: 32

Douglas J. Veale

Douglas J. Veale

University College Dublin

Publications: 29

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 28

Ulf Müller-Ladner

Ulf Müller-Ladner

University of Giessen

Publications: 27

Naveed Sattar

Naveed Sattar

University of Glasgow

Publications: 27

Carlo Selmi

Carlo Selmi

Humanitas University

Publications: 26

Piercarlo Sarzi-Puttini

Piercarlo Sarzi-Puttini

University of Milan

Publications: 26

Trending Scientists

Remco Dijkman

Remco Dijkman

Eindhoven University of Technology

Martin Roeb

Martin Roeb

German Aerospace Center

Geerd H. F. Diercksen

Geerd H. F. Diercksen

Max Planck Society

Eva Malmström

Eva Malmström

Royal Institute of Technology

Amy C. Rosenzweig

Amy C. Rosenzweig

Northwestern University

Xiaoyong Wei

Xiaoyong Wei

Xi'an Jiaotong University

Ryutaro Maeda

Ryutaro Maeda

National Institute of Advanced Industrial Science and Technology

Kaifu Huo

Kaifu Huo

Huazhong University of Science and Technology

Jianping Xu

Jianping Xu

McMaster University

Wouter Bleeker

Wouter Bleeker

Geological Survey of Canada

Ingemar Renberg

Ingemar Renberg

Umeå University

Meri K. Tulic

Meri K. Tulic

Inserm : Institut national de la santé et de la recherche médicale

Edward J. Calabrese

Edward J. Calabrese

University of Massachusetts Amherst

Matej Orešič

Matej Orešič

Örebro University

Daniel Read

Daniel Read

University of Warwick

Joan McCord

Joan McCord

Temple University

Something went wrong. Please try again later.